Neuronetics

$3.18 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Neuronetics

Neuronetics, Inc. provides healthcare services. The Company develops therapies for chronic neuro health disorders. Neuronetics serves patients in the United States.

Stock Analysis

last close $3.18
1-mo return 8.9%
3-mo return -0.3%
avg daily vol. 311.53T
52-week high 15
52-week low 1.98
market cap. $85M
forward pe -
annual div. -
roe -38.2%
ltg forecast -
dividend yield -
annual rev. $57M
inst own. 83%
baraka

Subscribe now for daily local and international financial news

Subscribe